Skip to main content
Midas Edge

Cycurion, Inc.

For the period ended Sep 30, 2025. Filed Nov 14, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 14, 2025

CYCU$2.470.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Changes in Stockholders’ Equity

Common stock subject to possibleredemption · Series A ConvertiblePreferred Stock · Series B ConvertiblePreferred Stock · Series C ConvertiblePreferred Stock · Series D Convertible PreferredStock · Series E ConvertiblePreferred Stock · Series GConvertiblePreferred Stock · Common Stock · Additional Paid-In Capital · AccumulatedDeficit · Total · Non- ControllingInterest · Total Stockholders’ Equity
Shares · Amount ($) · Shares · Amount($) · Shares · Amount($) · Shares · Amount($) · Shares · Amount($) · Shares · Amount($) · Shares · Amount($) · Shares · Amount($)
Balance as of December 31, 20245,796$1,917,309-$-3,000$-4,851$--$--$--$-353,087$35$6,671,084$(3,203,361)$3,467,758$-$3,467,758
Common stock redeemed (Mezzanine Equity)(3,163)(1,001,216)-------------------
Release of common stock subject to redemption(2,633)(916,093)------------2,633-916,093-916,093-916,093
Series A convertible preferred stock in exchange of Series A Convertible Preferred Stock categorized as liability--106,81611------------1,391,165-1,391,176-1,391,176
Series D convertible preferred stock in exchange of convertible notes--------6,666,666667------3,332,668-3,333,335-3,333,335
Common stock issued for conversion of Series B and D Convertible Preferred Stock----(2,999)---(6,516,666)(652)----417,17642610----
Common stock issued for exercise of warrants--------------234,830233,309,898-3,309,921-3,309,921
Common stock issued for business combination costs--------------25,00038,999,997-9,000,000-9,000,000
Common stock issued for settlement of liability--------------2,627-945,636-945,636-945,636
Common stock issued for employment agreement--------------16,6672249,998-250,000-250,000
SLG transaction----------51---16,9382509,069-509,071-509,071
Excise tax liability arising from redemption of Class A shares-----------------(10,012)(10,012)(3,464,218)(3,474,230)
Net loss-----------------(10,248,486)(10,248,486)-(10,248,486)
Balance as of March 31, 2025--106,816111-4,851-150,0001551---1,068,95810726,326,218(13,461,859)12,864,492(3,464,218)9,400,274
Series G convertible preferred stock in exchange of convertible notes and promissory notes------------3,318---4,183,891-4,183,891-4,183,891
Common stock issued for exercise of warrants--------------106,96811354,739-354,750-354,750
Common stock issued for settlement of liability--------------91,42091,028,469-1,028,478-1,028,478
Common stock issued for employment agreement--------------22,7822256,297-256,299-256,299
Common Stock Issued - Equity Line--------------38,3344265,500-265,504-265,504
SLG transaction--------------16,6712250,069-250,071-250,071
Net loss-----------------(5,188,755)(5,188,759)(101,659)(5,290,414)
Balance as of June 30, 2025-$-106,816$111$-4,851$-150,000$1551$-3,318$-1,345,133$135$32,665,183$(18,650,614)$14,014,730$(3,565,877)$10,448,853
Conversion of Series A Convertible Preferred stock for common stock--(106,816)(11)----------161,68716390,050-390,055-390,055
Common stock issued for exercise of warrants--------------66,6687193-200-200
Common stock issued for settlement of liability--------------8,267-120,530-120,530-120,530
Common stock issued for employment agreement--------------200,000202,081,380-2,081,400-2,081,400
Common Stock Issued - Equity Line--------------880,734885,608,9925,609,0805,609,080
Net loss-----------------(3,123,317)(3,123,317)(116,700)(3,240,017)
Balance as of September 30, 2025-$--$-1$-4,851$-150,000$1551$-3,318$-2,662,489$266$40,866,328$(21,773,931)$19,092,678$(3,682,577)$15,410,101
See accompanying notes to unaudited financial statements.
Series B Convertible Preferred Stock · Common Stock · AdditionalPaid-InCapital · Accumulated Deficit · TotalStockholders’Equity
Shares · Amount ($) · Shares · Amount ($)
Balance as of December 31, 20232,000$2,000,000498,941$499$7,678,574$(4,432,962)$3,246,111
Board compensation----10,000-10,000
Net loss-----(312,475)(312,475)
Balance as of March 31, 20242,0002,000,000498,9414997,688,574(4,745,437)2,943,636
Series B convertible preferred stock and warrants issued1,0001,000,000-----
Net income-----306,094306,094
Balance as of June 30, 20243,000$3,000,000498,941$499$7,688,574$(4,439,343)$3,249,730
Net income—————116,093116,093
Balance as of September 30, 2024$3,000$3,000,000$498,941$499$7,688,574$(4,323,250)$3,365,823
See accompanying notes to unaudited consolidated financial statements.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.